The present study was aimed at investigating the relationship between the new Clermont's phylogenetic groups, virulence factors, and pathogenicity island markers (PAIs) among uropathogenic Escherichia coli (UPEC) in Iran. This cross-sectional study was carried out on 140 UPEC isolates collected from patients with urinary tract infections in Bushehr, Iran. All isolates were subjected to phylogenetic typing using a new quadruplex-PCR method. The presence of PAI markers and virulence factors in UPEC strains was evaluated by multiplex PCR. The most predominant virulence gene was fimH (85%), followed by iucC (61.4%), papC (38.6%), hlyA (22.1%), cnf-1 (18.6%), afa (10.7%), papG and neuC (each 9.3%), ibeA (3.6%), and sfa/foc (0.7%). The most common phylogenetic group was related to B2 (39.3%), and the least common to A (0.7%). The most prevalent PAI marker was PAI IV536 (77.14%), while markers for PAI III536 (13.57%), PAI IIJ96 (12.86%), and PAI II536 (12.14%) were the least frequent among the UPEC strains. Meanwhile, the PAI IJ96 marker was not detected. There was a significant association between the phylogenetic group B2 and all the studied virulence genes and PAI markers. To our knowledge, this is the first study to compare the relationship between new phylogenetic groups, virulence genes and PAI markers in UPEC strains in Iran. The phylogenetic group B2 was predominantly represented among the studied virulence genes and PAI markers, indicating the preference of particular strains to carry virulence genes.

Bushehr University of Medical Sciences Bushehr Iran

Department of Microbiology and Parasitology Faculty of Medicine Bushehr University of Medical Sciences Bushehr Iran

The Persian Gulf Marine Biotechnology Research Center Bushehr University of Medical Sciences Bushehr Iran

Zobrazit více v PubMed

Ann Med Health Sci Res. 2015 Jul-Aug;5(4):241-6 PubMed

Environ Microbiol Rep. 2013 Feb;5(1):58-65 PubMed

J Infect Dis. 2004 Dec 15;190(12):2121-8 PubMed

Infect Immun. 2011 Mar;79(3):1225-35 PubMed

Folia Microbiol (Praha). 2016 May;61(3):261-8 PubMed

Lett Appl Microbiol. 2016 Jan;62(1):84-90 PubMed

J Infect Dev Ctries. 2015 Oct 29;9(10):1068-75 PubMed

Dan Med Bull. 2011 Apr;58(4):B4187 PubMed

Poult Sci. 2015 Dec;94(12):3025-33 PubMed

Biomed Res Int. 2015;2015:846219 PubMed

Rev Inst Med Trop Sao Paulo. 2008 Sep-Oct;50(5):255-60 PubMed

Appl Environ Microbiol. 2000 Oct;66(10):4555-8 PubMed

J Infect. 2015 Dec;71(6):615-26 PubMed

Microbiology. 2001 Jun;147(Pt 6):1671-6 PubMed

J Infect Dis. 2002 Mar 15;185(6):774-84 PubMed

BMC Microbiol. 2012 Jul 20;12:143 PubMed

Int J Antimicrob Agents. 2002 Jun;19(6):517-21 PubMed

J Infect Dis. 1998 Mar;177(3):642-50 PubMed

Appl Environ Microbiol. 2010 Oct;76(19):6698-700 PubMed

Pathogens. 2014 Jan 13;3(1):36-56 PubMed

Ann Clin Lab Sci. 2010 Fall;40(4):361-7 PubMed

Exp Mol Pathol. 2008 Aug;85(1):11-9 PubMed

Gastroenterol Hepatol Bed Bench. 2016 Fall;9(4):316-324 PubMed

Folia Microbiol (Praha). 2017 Mar;62(2):139-144 PubMed

Microb Pathog. 2016 Nov;100:293-298 PubMed

Braz J Med Biol Res. 2013 Oct 15;46(11):968-973 PubMed

Clin Chim Acta. 2000 Jul;297(1-2):305-11 PubMed

Vet Microbiol. 2013 Oct 25;166(3-4):590-4 PubMed

Clin Microbiol Infect. 2006 Sep;12(9):880-6 PubMed

J Clin Diagn Res. 2013 Dec;7(12):2727-31 PubMed

Appl Environ Microbiol. 2011 Apr;77(7):2303-8 PubMed

J Infect Dis. 2001 Jan 1;183(1):78-88 PubMed

Ann Clin Microbiol Antimicrob. 2012 Aug 06;11:23 PubMed

Adv Microb Physiol. 2014;65:337-72 PubMed

Ann Clin Microbiol Antimicrob. 2013 Apr 29;12:8 PubMed